DUBLIN--(BUSINESS WIRE)--FIRE1, a leading connected medical device solutions company, today announced the successful completion of a $120 million financing round to accelerate the company’s ...

FIRE1 says its device reduces the burden on healthcare staff by “enabling patients to engage in physician-directed self-management…making it easier to keep patients healthier and at home”.

Things are heating up for FIRE1, which posted a $120 million funding round to support its implant for tracking the hidden signs of heart failure. The Dublin-based company also announced that the ...

FIRE1's Norm heart failure management system. Irish medical technology company Fire1 secured $120 million in funding to launch a clinical trial of its new remote heart failure monitoring device.

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Fire1 said Tuesday it raised $120 million to complete ...

FIRE1 raised $120 million for its Norm system — a heart failure monitor implant that seeks to keep patients out of the hospital. By Katie Adams on January 07, 2025 6:44 pm. Share.

Fire1 Ltd. secured $120 million in financing to conduct a pivotal trial for its heart failure management system, Norm. The technology measures fluid in the inferior vena cava (IVC) and is expected to ...

Fire1 is pre-revenue and burning through cash. Its latest set of accounts, for the year to the end of December 2023, show it made a loss of €15 million and had accumulated losses of €65 million.

Mr. Wasserman added, “FIRE1’s unique approach to heart failure—a more direct measure of volume instead of relying on proxies—has generated significant excitement in the clinical community.